Menu
Back to Journals » Medical Devices: Evidence and Research » Volume 9
Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System
Authors Hwang S, Takata M, Fujioka K, Fuller W
Received 11 February 2016
Accepted for publication 29 April 2016
Published 17 August 2016 Volume 2016:9 Pages 291—299
DOI https://doi.org/10.2147/MDER.S106223
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Lucy Goodman
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Stephanie S Hwang,1 Mark C Takata,1 Ken Fujioka,2 William Fuller1
1Division of General/Bariatric Surgery, Scripps Clinic Weight Management, 2Division of Diabetes and Endocrinology, Scripps Clinic, La Jolla, CA, USA
Abstract: There are many different methods of treating obesity, ranging from various medical options to several surgical therapies. This paper briefly summarizes current surgical options for weight loss with a focus on one of the newest US Food and Drug Administration-approved devices for surgical weight loss therapy, the Maestro Rechargeable System. Also known as the vagal blocking for obesity control implantable device, this tool blocks vagal nerve activity to induce weight loss.
Keywords: VBLOC device, vagal, vagus, obesity
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.